Carmel’s elected leaders are working to mend differences after a contentious budget-writing season during which conflicts ...
To explore the opportunities and challenges facing the city, the Marble Falls Economic Development Corporation convened a ...
You clicked, and the page blinked. Then a stark prompt questioned your humanity, nudging you to prove you’re real today. The ...
They are each built on one of three paradigms that has dominated international relations theory since World War II: realism, liberalism, and constructivism. Realists see politics as rooted in anarchy, ...
More than six decades later, what has emerged is a military-narrational complex, in which war presents too good a story not to tell, over and over again. States, and now nonstate actors, have been ...
Alnylam’s closely watched launch of its rare disease drug Amvuttra continued to outpace Wall Street expectations. | Riding its March expansion into the heart condition of ATTR-CM, sales of Amvuttra ...
Medpage Today on MSN
ATTR Trial's Safety Freeze; Heart Failure After Twins; Sotatercept Approval Expands
As alternatives to intravascular lithotripsy, cutting balloon angioplasty and super-high-pressure non-compliant balloons were noninferior in the Short-CUT and VICTORY trials, as highlighted by the ...
Intellia Therapeutics has paused dosing in its Phase 3 MAGNITUDE trials after a patient experienced severe liver toxicity, as ...
AstraZeneca and Ionis are planning a US launch next month for Wainua, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR), after getting FDA ...
Despite a sceptical appraisal by FDA reviewers, Alnylam's Onpattro has been recommended for approval as a treatment for transthyretin amyloidosis cardiomyopathy (ATTR-CM) by the regulator's advisors.
India face Australia in the ICC Women's World Cup semi-final - follow live scores, radio commentary, video highlights and ...
Microsoft’s NLWeb bridges websites and AI agents. Learn how to make your schema work harder – powering smarter discovery and visibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results